313 related articles for article (PubMed ID: 27255162)
21. Comprehensive genomic profiling reveals ubiquitous KRAS mutations and frequent PIK3CA mutations in ovarian seromucinous borderline tumor.
Wu RC; Chen SJ; Chen HC; Tan KT; Jung SM; Lin CY; Chao AS; Huang KG; Chou HH; Chang TC; Chao A; Lai CH
Mod Pathol; 2020 Dec; 33(12):2534-2543. PubMed ID: 32616873
[TBL] [Abstract][Full Text] [Related]
22. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
Ang MK; Ooi AS; Thike AA; Tan P; Zhang Z; Dykema K; Furge K; Teh BT; Tan PH
Breast Cancer Res Treat; 2011 Sep; 129(2):319-29. PubMed ID: 20945089
[TBL] [Abstract][Full Text] [Related]
23. Adenomyoepitheliomas of the Breast Frequently Harbor Recurrent Hotspot Mutations in PIK3-AKT Pathway-related Genes and a Subset Show Genetic Similarity to Salivary Gland Epithelial-Myoepithelial Carcinoma.
Lubin D; Toorens E; Zhang PJ; Jaffer S; Baraban E; Bleiweiss IJ; Nayak A
Am J Surg Pathol; 2019 Jul; 43(7):1005-1013. PubMed ID: 31094929
[TBL] [Abstract][Full Text] [Related]
24. Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.
Ng CCY; Md Nasir ND; Loke BN; Tay TKY; Thike AA; Rajasegaran V; Liu W; Lee JY; Guan P; Lim AH; Chang KTE; Gudi MA; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Yip GWC; Bay BH; Tan P; Teh BT; Tan PH
Mod Pathol; 2021 Jul; 34(7):1320-1332. PubMed ID: 33727697
[TBL] [Abstract][Full Text] [Related]
25. MED12, TERT promoter and RBM15 mutations in primary and recurrent phyllodes tumours.
Garcia-Dios DA; Levi D; Shah V; Gillett C; Simpson MA; Hanby A; Tomlinson I; Sawyer EJ
Br J Cancer; 2018 Jan; 118(2):277-284. PubMed ID: 29315289
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical and molecular markers in breast phyllodes tumors.
Korcheva VB; Levine J; Beadling C; Warrick A; Countryman G; Olson NR; Heinrich MC; Corless CL; Troxell ML
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):119-25. PubMed ID: 21030860
[TBL] [Abstract][Full Text] [Related]
27. MED12 exon 2 mutations in phyllodes tumors of the breast.
Nagasawa S; Maeda I; Fukuda T; Wu W; Hayami R; Kojima Y; Tsugawa K; Ohta T
Cancer Med; 2015 Jul; 4(7):1117-21. PubMed ID: 25865354
[TBL] [Abstract][Full Text] [Related]
28. Novel genetic aberrations in breast phyllodes tumours: comparison between prognostically distinct groups.
Tan WJ; Lai JC; Thike AA; Lim JC; Tan SY; Koh VC; Lim TH; Bay BH; Tan MH; Tan PH
Breast Cancer Res Treat; 2014 Jun; 145(3):635-45. PubMed ID: 24831776
[TBL] [Abstract][Full Text] [Related]
29. Phyllodes tumors of the breast segregate in two groups according to genetic criteria.
Laé M; Vincent-Salomon A; Savignoni A; Huon I; Fréneaux P; Sigal-Zafrani B; Aurias A; Sastre-Garau X; Couturier J
Mod Pathol; 2007 Apr; 20(4):435-44. PubMed ID: 17334353
[TBL] [Abstract][Full Text] [Related]
30. Two progressed malignant phyllodes tumors of the breast harbor alterations in genes frequently involved in other advanced cancers.
Reinisch M; Kuemmel S; Breit E; Theuerkauf I; Harrach H; Schindowski D; Moka D; Bettstetter M; Bruzas S; Chiari O
Orphanet J Rare Dis; 2021 Aug; 16(1):363. PubMed ID: 34399808
[TBL] [Abstract][Full Text] [Related]
31. Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ; Ng CCY; Rajasegaran V; Guan P; Selvarajan S; Thike AA; Nasir NDBM; Koh VCY; Tan BKT; Ong KW; Teh BT; Tan PH
Breast Cancer Res Treat; 2019 Apr; 174(2):365-373. PubMed ID: 30511242
[TBL] [Abstract][Full Text] [Related]
32. MED12 is frequently mutated in breast phyllodes tumours: a study of 112 cases.
Ng CC; Tan J; Ong CK; Lim WK; Rajasegaran V; Nasir ND; Lim JC; Thike AA; Salahuddin SA; Iqbal J; Busmanis I; Chong AP; Teh BT; Tan PH
J Clin Pathol; 2015 Sep; 68(9):685-91. PubMed ID: 26018969
[TBL] [Abstract][Full Text] [Related]
33. Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression.
Kersting C; Kuijper A; Schmidt H; Packeisen J; Liedtke C; Tidow N; Gustmann C; Hinrichs B; Wülfing P; Tio J; Boecker W; van Diest P; Brandt B; Buerger H
Lab Invest; 2006 Jan; 86(1):54-61. PubMed ID: 16258523
[TBL] [Abstract][Full Text] [Related]
34. Malignant phyllodes tumor of the breast with liposarcomatous differentiation and intraductal hyperplasia.
Ayadi-Kaddour A; Zeddini A; Braham E; Ismail O; Mlika M; Guelmami K; El Mezni F
Breast Dis; 2015; 35(1):59-62. PubMed ID: 25061020
[TBL] [Abstract][Full Text] [Related]
35. Case report: Osteosarcomatous differentiation in the lung metastasis of a malignant phyllodes tumor.
Liu R; Xue J; Liu W; Jiang B; Shi F; Wang Z; Li P
Front Med (Lausanne); 2023; 10():1141353. PubMed ID: 37025961
[TBL] [Abstract][Full Text] [Related]
36. Malignant phyllodes tumor with liposarcomatous differentiation: Diagnosed on cytology.
Kuppusamy DA; Jinkala S; Thambiraj P; Stephen N; Gochhait D; Siddaraju N; Dharanipragada K
Diagn Cytopathol; 2021 Jun; 49(6):E226-E230. PubMed ID: 33378115
[TBL] [Abstract][Full Text] [Related]
37. Frequent MED12 mutations in phyllodes tumours of the breast.
Yoshida M; Sekine S; Ogawa R; Yoshida H; Maeshima A; Kanai Y; Kinoshita T; Ochiai A
Br J Cancer; 2015 May; 112(10):1703-8. PubMed ID: 25839987
[TBL] [Abstract][Full Text] [Related]
38. Targeted Genomic Profiling Reveals Recurrent KRAS Mutations in Mesonephric-like Adenocarcinomas of the Female Genital Tract.
Mirkovic J; McFarland M; Garcia E; Sholl LM; Lindeman N; MacConaill L; Dong F; Hirsch M; Nucci MR; Quick CM; Crum CP; McCluggage WG; Howitt BE
Am J Surg Pathol; 2018 Feb; 42(2):227-233. PubMed ID: 28984674
[TBL] [Abstract][Full Text] [Related]
39. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma.
Krings G; Chen YY
Mod Pathol; 2018 Nov; 31(11):1661-1674. PubMed ID: 29946183
[TBL] [Abstract][Full Text] [Related]
40. Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.
Tan BY; Md Nasir ND; Chang HY; Ng CCY; Guan P; Nagarajan S; Rajasegaran V; Lee JY; Lim JQ; Thike AA; Teh BT; Tan PH
Mod Pathol; 2020 Sep; 33(9):1732-1745. PubMed ID: 32322022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
